Insider Selling: Addus HomeCare (NASDAQ:ADUS) EVP Sells $63,551.20 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) EVP Michael Wattenbarger sold 592 shares of the firm’s stock in a transaction on Tuesday, February 24th. The shares were sold at an average price of $107.35, for a total transaction of $63,551.20. Following the transaction, the executive vice president directly owned 9,744 shares of the company’s stock, valued at $1,046,018.40. The trade was a 5.73% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $103.53 on Friday. The stock has a market cap of $1.92 billion, a price-to-earnings ratio of 19.87, a P/E/G ratio of 1.44 and a beta of 0.91. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $124.43. The company’s fifty day moving average is $109.22 and its 200 day moving average is $112.95. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.11.

Hedge Funds Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently modified their holdings of the business. Invesco Ltd. grew its position in shares of Addus HomeCare by 7.1% during the 4th quarter. Invesco Ltd. now owns 416,857 shares of the company’s stock worth $44,766,000 after buying an additional 27,683 shares during the period. Caitlin John LLC bought a new position in Addus HomeCare during the fourth quarter worth $183,000. Empowered Funds LLC grew its holdings in Addus HomeCare by 186.1% in the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock worth $7,617,000 after purchasing an additional 46,137 shares during the period. XTX Topco Ltd bought a new stake in Addus HomeCare in the fourth quarter valued at $432,000. Finally, VARCOV Co. bought a new stake in Addus HomeCare in the fourth quarter valued at $382,000. 95.35% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on ADUS. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday. Royal Bank Of Canada reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday. Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the stock a “buy” rating in a research report on Wednesday, January 7th. Wall Street Zen raised shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Monday, February 23rd. Finally, TD Cowen reissued a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $134.33.

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Large institutional holders have been adding to positions in recent quarters, which provides a steady shareholder base and underlying demand. MarketBeat ADUS Institutional Holdings
• Positive Sentiment: Stephens kept an “Overweight” rating on ADUS and a $135 price target (trimmed from $140), signaling continued analyst conviction even after the cut. That backing can limit downside over the medium term. Stephens PT story
• Neutral Sentiment: Short‑interest figures are inconsistent across feeds (some reports show zero or NaN, others show a material rise). This data noise makes it hard to interpret immediate short pressure — confirm with FINRA/exchange data before acting. MarketBeat short interest
• Negative Sentiment: Significant insider selling across Feb. 24–25: CEO R. Dirk Allison and multiple EVPs sold several thousand shares in aggregate (CEO filings disclosed to the SEC). Large, concentrated insider sales are weighing on sentiment and likely contributed to today’s weakness. CEO SEC filing
• Negative Sentiment: Media flagged a “pessimistic forecast” narrative after Stephens trimmed its target, which can reinforce short‑term selling despite the retained Overweight rating. That coverage likely amplified intra‑day pressure. AmericanBankingNews piece
• Negative Sentiment: Smaller insider sales (e.g., EVP Cliff Blessing) were also reported; while individually minor, the wave of coordinated filings increases headline risk and may trigger mechanical selling. InsiderTrades alert

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.